IGM Biosciences | 8-K: IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
IGM Biosciences | 10-Q: Q2 2024 Earnings Report
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Strohl William
IGM Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(9.9%),Invus Public Equities Advisors, LLC(9.9%), etc.
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Hambleton Julie
IGM Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Takimoto Chris H
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Keyt Bruce
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Tahir Misbah
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Harler Mary Beth
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Decker Lisa Lynn
IGM Biosciences | SC TO-I/A: Third party tender offer statement (Amendment)
IGM Biosciences | 8-K: Current report
IGM Biosciences | SC TO-I/A: Third party tender offer statement (Amendment)
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Redmile Group, LLC
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Lee Michael Stewart
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Topsoe Jakob Haldor
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Topsoe Christina Teng
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Thompson Elizabeth H.Z.
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director BEHRENS M KATHLEEN
No Data
No Data